Biologic API Sourcing Center

Biologic API Sourcing Center

Active Pharmaceutical Ingredients (API) for biologics can at times be somewhat more complicated than small-molecule API, involving both sophisticated culture and fermentation of microorganisms as well as chemical compounds and processes.

High degrees of purity and process controls must be maintained in facilities capable of handling large molecules. As biologic products continue to reach commercial acceptance, the needs for capacity and specific capabilities will increase, as will the art and science of developing API.

How can we help?

Looking for help with your Biologic API project? If you're searching for information or a supplier, let Life Science Connect lend you a hand.

Submit A Question

Biologic API CMOs

Biologic API CMO - AcuraBio
AcuraBio

AcuraBio is an Australia-based contract development and manufacturing organization (CDMO) that provides development and biomanufacturing to the pharmaceutical, biotechnology, and veterinary industries.

Australia offers biopharma companies a streamlined regulatory framework and generous tax incentives making it a prime location for biotech research. For more than 20 years, AcuraBio has been a world leader specializing in recombinant proteins and vaccines and complex live therapeutic products.

Biologic API CMO - Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services

Working with Ajinomoto Bio-Pharma Services, you get a trusted CDMO partner that has the power to make your every challenge our own, sharing your unwavering tenacity and dedication from pre-clinical program to commercial successes. We leverage our broad range of capabilities and services at our sites in Belgium, India, Japan, and the US to support your program goals.

Capabilities

Biologic API CMO - Asymchem
Asymchem

For over 20 years, Asymchem has been positioned and structured to act as a true partner for pharmaceutical and biotech companies worldwide by offering integrated solutions across all stages of drug development and into commercialization.

As a CDMO with 8 state-of-the-art manufacturing sites, Asymchem's breadth of capabilities spans conventional batch manufacturing, and we are a world leader in green chemistry.

Capabilities


Have questions about selecting the right CMO?

The Life Science Connect team can help. We'll match your needs with the right companies.

Contact us via email for assistance.


Biologic API CMO - Catalent
Catalent

Catalent is a global leader in providing integrated services, superior drug delivery technologies and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics and consumer health products.

Capabilities

Biologic API CMO - Celanese
Celanese

Celanese Corporation is a global chemical leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our businesses use the full breadth of Celanese's global chemistry, technology and commercial expertise to create value for our customers, employees, shareholders and the corporation.

Capabilities

Biologic API CMO - Charles River
Charles River

For over 70 years, Charles River has provided essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe, helping to accelerate their research and drug development efforts. With over 90 sites globally, we're ready to tackle your product's most unique challenges.


Biologic API CMO - CHIRON® Recombinant Proteins
CHIRON® Recombinant Proteins

CHIRON® Recombinant Proteins partners with companies interested in developing complex proteins into therapeutics, vaccines, or diagnostics. Our state-of-the-art GMP biological manufacturing CMF facility located in the San Francisco Bay Area is well positioned to provide long-term, high-quality, commercial manufacturing of recombinant biologic drug substances to our customers, regardless of their global location.

Biologic API CMO - Emergent CDMO
Emergent CDMO

Emergent CDMO is dedicated to helping biopharma innovators bring life-saving, life-extending therapies to patients throughout the world. We have supported the development and manufacture of over 40 commercial and more than 200 clinical programs for our partners. As a dedicated and experienced global CDMO solutions provider, we can support preclinical to commercial production of therapeutics and vaccines.

Biologic API CMO - FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies

FUJIFILM Diosynth Biotechnologies is a CDMO Partner for Life. We combine technical leadership in cell culture, microbial fermentation and advanced therapies with world class cGMP manufacturing facilities and superior program management to advance tomorrow's medicines.


Biologic API CMO - Jefferson Institute for Bioprocessing (JIB)
Jefferson Institute for Bioprocessing (JIB)

With the mission of providing state-of-the-art education, training and contract services in the fast-emerging field of biopharmaceutical processing, Jefferson Institute for Bioprocessing (JIB) formally opened its doors in 2019 and is the first—and only—specialized education, training and CDMO for biopharmaceutical processing in North America. JIB's 25,000 sq. ft fully closed-processing, CNC, GMP-simulated pilot scale and process development facility houses ready-to-use technologies in fully flexible, ballroom designed suites.

Biologic API CMO - IDT Biologika
Kymanox Corporation

Kymanox is a life science professional services organization that offers engineering, scientific, and compliance support to companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries. With its diverse team, Kymanox helps clients navigate commercialization challenges that arise throughout a product's lifecycle – from early development to post-market commercialization – with optimized safety, quality, efficacy, and accessibility.

Biologic API CMO - Lonza
Lonza

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our unparalleled breadth of offerings enables our customers to commercialize their discoveries and innovations in the healthcare industry.


Biologic API CMO - Patheon, by Thermo Fisher Scientific
Patheon, by Thermo Fisher Scientific

Thermo Fisher Scientific’s Patheon provides industry-leading pharma services solutions for drug development, clinical trial logistics and commercial manufacturing to customers of all sizes.

Biologic API CMO - Nanoform
Nanoform

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners to improve the lives of patients globally by overcoming drug development and delivery challenges through its game-changing nanoforming technologies, novel formulation capabilities and GMP manufacturing facilities. The company's dedicated, multi-disciplinary team has a combined experience of launching 100+ medicines.

Biologic API CMO - Resilience US, Inc.
Resilience US, Inc.

Resilience is a manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions with the aim to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale. Resilience seeks to offer regulatory capabilities and flexible and adaptive facilities to serve partners of all sizes.


Biologic API CMO - Samsung Biologics
Samsung Biologics

Samsung Biologics is a full-service provider offering development and cGMP manufacturing services. We deliver a broad range of services from development and manufacturing to fill and finish, covering both clinical molecules and commercial products.

Biologic API CMO - Syngene International
Syngene International

Our biomanufacturing facility offers end-to-to end, multiple platform technologies and cGMP manufacturing capabilities for clinical and commercial supply. We provide services for Mammalian, Microbial, Baculovirus and Yeast-derived recombinant products. These include antibodies, bispecific antibodies, antibody fragments as well messenger RNA (mRNA), plasmid DNA (pDNA), Virus-like particles (VLPs), and microbiome. We employ protocol-driven, technology transfer processes to seamlessly integrate projects from customers into our facilities.

Capabilities